Gland Pharma informs about press release

04 Mar 2026 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of USFDA tentative approval for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC).

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1607.00 9.75 (0.61%)
20-Mar-2026 12:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.35
Dr. Reddys Lab 1294.50
Cipla 1256.40
Zydus Lifesciences 889.90
Lupin 2315.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×